1. Introduction {#s0005}
===============

The prevalence of overweight and obesity has been rapidly increasing in the world. According to World Health Organization (WHO), more than 1.9 billion adults aged above 18 years and 42 million children under the age of 5 were overweight or obese globally in 2014. Obesity is characterized by abnormal or excessive body fat accumulation, which is a risk factor for type 2 diabetes, hypertension, cardiovascular diseases, cancers, and cognitive dysfunction ([@bb0075]). Therefore, obesity has become a major public health challenge. It is generally accepted that obesity is attributed to a shift in dietary and physical activity habits ([@bb0030]). In addition to the unhealthy lifestyle, genetic factors are assumed to play an important role in obesity susceptibility, which hereditability has been estimated about 61%--80% ([@bb0090]). Numerous genes related to obesity have been found by candidate gene and genome-wide association approaches ([@bb0100]).

One commonly studied candidate gene for obesity is G protein β-polypeptide 3 gene (*GNB3*). Heterotrimeric G proteins are composed of an alpha, a beta, and a gamma subunit encoded by families of related genes, which are critical to translate signals from the cell surface into a cellular response in all cells of the body ([@bb0020]). A study by Wang HY et al. showed a critical role in adipogenesis played by G proteins ([@bb0150]). Elevation expression of Gi alpha 2 subunit or expression of constitutively active Gi alpha 2 promotes lipid accumulation and adipogenic conversion of cells ([@bb0135]). In addition, transgenic mice lacking the Gi alpha 2 subunit are lean and deficient in fat mass ([@bb0080]). G protein beta subunits are important regulators of alpha subunits and of certain signal transduction. A recent study by Goldlust IS et al. reported that the duplication of the *GNB3* gene has been linked to an obesity phenotype not only in humans but also in the transgenic mouse model ([@bb0035]). A single-nucleotide polymorphism (c.825C \> T, rs5443) in exon 10 of *GNB3* has been reported that associated with the occurrence of a splice variant Gβ3s ([@bb0125]). Despite a deletion of 41 amino acids and one WD repeat domain of the G beta subunit, splice variant Gβ3s is proved to be a biologically active protein and can ultimately enhance signal transduction via pertussis toxin-sensitive G proteins ([@bb0125], [@bb0105]). *GNB3* c.825C \> T polymorphism influences G protein receptor mediated signal transduction, including lipolysis. Functional studies have established that *GNB3* 825TT homozygote has lowered Gβ3 protein and impaired the function of adrenoceptors, thus reducing lipolysis in human fat cells ([@bb0110], [@bb0040]).

The first study on the relationship between overweight/obesity and *GNB3* c.825C \> T polymorphism was conducted in 1999 by Siffert W et al. They found a significant association between the 825T allele and overweight and obesity with odds ratios between 2 and 3 in Germans, Chinese, and black South Africans ([@bb0115]). Since then, much research has focused on the association between *GNB3* c.825C \> T polymorphism and overweight/obesity. However, the results were inconsistent and conflicting. Therefore, we performed a meta-analysis of previous studies to comprehensively evaluate the relationship between *GNB3* c.825C \> T polymorphism and overweight/obesity susceptibility.

2. Methods {#s0010}
==========

2.1. Search strategy {#s0015}
--------------------

We searched the PubMed, ProQuest Health & Medical Complete, Web of Science, Chinese Biomedical Medical databases (CBM), Chinese National Knowledge Infrastructure (CNKI), and Wan Fang (Chinese) databases for all publications on the association between *GNB3* c.825C \> T polymorphism and the risk of overweight and obesity, using the following search terms: ('G protein beta 3 polypeptide' or 'GNB3') and ('obesity' or 'obese' or 'overweight' or 'body mass index' or 'BMI') and ('polymorphism' or 'variant'). All studies were published from 1999, when the first study of the topic was reported, to 20 May, 2015. There were no language limitations on the search. "Related articles" option in PubMed was examined. Reference lists from the retrieved articles were also screened.

2.2. Inclusion and exclusion criteria {#s0020}
-------------------------------------

The inclusion criteria were as follows: 1) the study had a case control design for the association between the *GNB3* c.825C \> T and the risk of overweight and obesity. 2) Complete information of allelic frequencies and genotypic frequencies was available in cases and controls for calculating the odds ratio (OR) with 95% CI directly and indirectly. 3) The criteria for diagnosis was established using body mass index (BMI) cut-off points for obesity. We have excluded studies for 1) review articles, case reports, editorials, or animal research, and 2) overlapping and insufficient data.

2.3. Quality assessment and data extraction {#s0025}
-------------------------------------------

The quality of the studies was critically assessed using the Newcastle--Ottawa Quality Assessment Scale (NOS) by two authors (Li HL and Zhang YJ). The following aspects of each study were appraised: selection of cases and controls, comparability, and outcome or exposure. Quality scores ranged from 0 to 9. In addition, we assessed the quality of included studies by *P* value of Hardy--Weinberg equilibrium (HWE) for the control genotype. Studies only consistent with HWE were scored in part of "selection of control" ([Table 2](#t0010){ref-type="table"}). The study that scored seven or more stars was considered as a high-quality study, otherwise, the low-quality study. Guidelines from meta-analysis of observational studies in epidemiology (MOOSE) group were followed to extract the following data: first author, publication year, country and ethnicity, source of control, sample size and mean age of cases and controls, genotyping method, *P* value for HWE, BMI cut-off points, number of gender (males/females), and the genotypic and allelic frequencies in cases and controls. The studies were reviewed by two authors respectively. The results were compared and disagreements were solved with consensus.

2.4. Statistical analysis {#s0030}
-------------------------

The STATA 12.0 software (StataCorp, College Station, TX, USA) was used for all statistical analyses. The association between *GNB3* c.825C \> T polymorphism and overweight/obesity was assessed using crude odds ratio (OR) with 95% confidence interval (CI). The pooled ORs were determined for allelic model (T versus C), homozygous model (TT versus CC), heterozygous model (CT versus CC), recessive model (TT versus CT/CC), and dominant model (CT/TT versus CC). The pooled OR was calculated using the Z test with the significance set at *P* \< 0.05. HWE was assessed using the Chi-square test. The heterogeneity between studies was evaluated using the *I*^2^ test and *Q* statistic test. The value of *I*^2^ lies between 0% and 100%, and the larger value indicates increasing heterogeneity ([@bb0045]). If heterogeneity was observed between studies (*I*^2^ \> 50% or *P* \< 0.05), the DerSimonian and Laird method for random-effects model was used to calculate the pooled OR and 95% CI. Otherwise, the Mantel--Haenszel method for fixed-effects model was adopted for the meta-analysis. Stratification analysis according to the *P* value of HWE, ethnicity, mean age, gender, and quality scores of studies were also performed to evaluate the association. Meta-regression was applied to explore the sources of between-study heterogeneity. The study publication year, ethnicity, BMI cut-off points, number of cases and controls, quality scores of studies and the *P* value of HWE were regarded as the potential confounding factors. Sensitivity analysis was performed to evaluate the effect of individual study on pooled results and assess the stability of results. The potential publication bias was graphically represented by funnel plots, and the funnel plot asymmetry was evaluated with Egger\'s linear regression test and Begg\'s test ([@bb0025], [@bb0005]).

3. Results {#s0035}
==========

3.1. Study characteristics {#s0040}
--------------------------

A total of 780 studies were identified by searching databases. After carefully screening titles and abstracts, 26 articles were chosen after removing duplicates, animal research, and not significantly relevant papers. Finally, 11 articles including 15 case--control studies with a total of 3171 cases of overweight/obesity and 7225 controls were included after detailed evaluation in the present meta-analysis ([Fig. 1](#f0005){ref-type="fig"}). And the main characteristics of included studies are presented in [Table 1](#t0005){ref-type="table"}. Two studies used polymerase chain reaction--restriction fragment length polymorphism (PCR--RFLP) as genotyping methods ([@bb0070], [@bb0060]), whereas thirteen studies used Taqman assay ([@bb0115], [@bb0155], [@bb0015], [@bb0165], [@bb0065], [@bb0140], [@bb0010], [@bb0055], [@bb0095]). All studies showed that source of controls was population-based except one ([@bb0060]). The quality of the studies was assessed by NOS scale and quality scores of the included studies were detailed in [Table 2](#t0010){ref-type="table"}. Some included studies were separately analyzed to investigate the relationship between *GNB3* c.825C \> T polymorphism and overweight or extremely obese alone. We also conducted a meta-analysis to estimate the association between *GNB3* c.825C \> T polymorphism and overweight or extremely obese respectively. The characteristics of studies of overweight or extremely obese and *GNB3* c.825C \> T polymorphism are showed in [Table 3](#t0015){ref-type="table"}.

3.2. Meta-analysis {#s0045}
------------------

In the meta-analysis of all involved studies, there was a significant association between *GNB3* c.825C \> T polymorphism and overweight/obesity under an allelic model (OR = 1.08, 95% CI: 1.02--1.16, *P* = 0.017), a homozygous genetic model (OR = 1.19, 95% CI: 1.04--1.36, *P* = 0.014), as well as a recessive genetic model (OR = 1.19, 95% CI: 1.06--1.32, *P* = 0.002) ([Table 4](#t0020){ref-type="table"}). But no significant association was observed under a heterozygous genetic model (OR = 1.00, 95% CI: 0.89--1.12, *P* = 0.994), and a dominant genetic model (OR = 1.05, 95% CI: 0.94--1.17, *P* = 0.350) ([Table 4](#t0020){ref-type="table"}). Furthermore, the *I*^2^ test and *Q* statistic test suggested an existence of heterogeneity in included studies under an allelic model, a homozygous model, a recessive model, and a dominant model. Therefore, the random effects model was used to calculate the pooled effects in those models. The results showed a significant association in a recessive model (OR = 1.22, 95% CI: 1.04--1.44, *P* = 0.015) between GNB3 c.825C \> T polymorphism and overweight/obesity, but not in an allelic model (OR = 1.10, 95% CI: 0.99--1.22, *P* = 0.076) and in a homozygous genetic model (OR = 1.23, 95% CI: 0.98--1.24, *P* = 0.078) ([Table 4](#t0020){ref-type="table"}).

Subgroup analysis was conducted in four models in which heterogeneity existed. In the stratified analyses using the *P* value of HWE, the results indicated only significant association in a recessive model consistent with HWE (OR = 1.15, 95% CI: 1.00--1.32, *P* = 0.043) ([Table 5](#t0025){ref-type="table"}, and [Fig. 2](#f0010){ref-type="fig"}). Stratified analyses by ethnicity (categorized as Asian, Caucasian, and Black African) suggested only slightly significant association in the recessive model (OR = 1.19, 95% CI: 1.00--1.43, *P* = 0.055) in the Asian subgroup ([Table 5](#t0025){ref-type="table"}). In the subgroup analysis by mean age (categorized as mean age less than 30 years and mean age more than 30 years), we found only significant association in the recessive model (OR = 1.26, 95% CI: 1.04--1.55, *P* = 0.029) in the mean age less than 30 years subgroup ([Table 5](#t0025){ref-type="table"}, and [Fig. 3](#f0015){ref-type="fig"}). Stratified analyses by gender (categorized as all, male and female) showed a significant association between GNB3 c.825C \> T polymorphism and overweight/obesity in the male subgroup under an allelic model (OR = 1.27, 95% CI: 1.06--1.51, *P* = 0.008), a homozygous model (OR = 1.68, 95% CI: 1.11--2.54, *P* = 0.014), a recessive model (OR = 1.30, 95% CI: 1.08--1.56, *P* = 0.005) and a dominant model (OR = 1.38, 95% CI: 1.00--1.88, *P* = 0.049) ([Table 5](#t0025){ref-type="table"}, and [Fig. 4](#f0020){ref-type="fig"}). In addition, we stratified the studies by quality scores, and found that an obvious association was found in a high-quality study under the recessive model (OR = 1.30, 95% CI: 1.01--1.66, *P* = 0.040) ([Table 5](#t0025){ref-type="table"}).

3.3. Heterogeneity analysis {#s0050}
---------------------------

The subgroup analysis revealed that heterogeneity was removed in the analysis of mean age above 30 years, and black African subgroup. Moreover, the heterogeneity consistent with the HWE subgroup was obviously removed with an *I*^2^ value of 4.5% in the recessive model. In the allelic model, meta-regression showed that the *P* value of HWE, publication year, and study quality scores were the sources of heterogeneity between studies (*P* = 0.043, *P* = 0.055, *P* = 0.047, respectively), as well as in the homozygous model (*P* = 0.013, *P* = 0.013, *P* = 0.013, respectively). Furthermore, in the recessive model, meta-regression also revealed that the *P* value of HWE, publication year, and study quality scores were the sources of heterogeneity (*P* = 0.008, *P* = 0.009, *P* = 0.021, respectively), those three covariates were able to explain 86.47% of between-study variance, which was consistent with the subgroup analysis. In addition, meta-regression revealed that the study quality score was the source of heterogeneity in the dominant model (*P* = 0.080), which also was in agreement with the subgroup analysis.

3.4. Sensitivity analysis and publication bias {#s0055}
----------------------------------------------

Sensitivity analysis was performed to evaluate the stability of results by excluding individual study each time. The analysis results demonstrated that the association was more significant after excluding the study by Hinney et al. under an allelic model (OR = 1.12, 95% CI: 1.01--1.24, *P* = 0.027), a homozygous model (OR = 1.28, 95% CI: 1.01--1.61, *P* = 0.040), and a recessive model (OR = 1.25, 95% CI: 1.06--1.47, *P* = 0.009), and the study by Zhou et al. under an allelic model (OR = 1.12, 95% CI: 1.00--1.24, *P* = 0.041), a homozygous model (OR = 1.27, 95% CI: 1.00--1.60 *P* = 0.042), and a recessive model (OR = 1.24, 95% CI: 1.05--1.47, *P* = 0.010). Moreover, the inter-study heterogeneity was completely removed after excluding the study by Chen et al. in recessive model. Deleting other individual study make little difference in corresponding pooled effects of all models (data not shown), which suggesting that our results are statistically robust. The funnel in all models revealed no obvious publication bias. [Fig. 5](#f0025){ref-type="fig"} showed the funnel plots of the recessive model. The results were confirmed by Egger\'s linear regression test and Begg\'s test ([Table 4](#t0020){ref-type="table"}).

3.5. Association between *GNB3* c.825C \> T polymorphism with overweight or extremely obese {#s0060}
-------------------------------------------------------------------------------------------

Of 11 articles, five studies were separately analyzed the relationship between overweight and *GNB3* c.825C \> T polymorphism. We evaluated the relationship between overweight and *GNB3* c.825C \> T polymorphism alone. The results revealed a significant association between overweight and *GNB3* c.825C \> T polymorphism in all inherited models (*P* \< 0.05) except a recessive model (*P* = 0.084) ([Table 6](#t0030){ref-type="table"}). As noted, two studies were individually analyzed the association between extremely obese and *GNB3* c.825C \> T polymorphism. In contrast, no significant association was found in all inherited models (*P* \> 0.05) between extremely obese and *GNB3* c.825C \> T polymorphism ([Table 6](#t0030){ref-type="table"}).

4. Discussion {#s0065}
=============

In the present meta-analysis with 11 eligible articles of total 10,396 subjects (3171 cases of overweight/obesity and 7225 controls), it is demonstrated that *GNB3* 825TT and the risk of overweight/obesity were significantly associated in recessive model, as well as overweight only in all models, but not in extremely obese. Further stratified analysis revealed that *GNB3* 825TT homozygote was a high risk factor of overweight/obesity in males or under age of 30 populations. To our knowledge, this is the first study to examine the subgroup analysis of mean age and potential sex differences in overweight/obesity with the association of *GNB3* c.825C \> T polymorphism.

Generally, it is considered that genes exert their effects across different ethnic groups. We performed a subgroup analysis by ethnicity, but no association was found under any inherited models. It is worth noting that the number of studies from Asian population was much more than for other races. And it is likely that the relationship between *GNB3* c.825C \> T polymorphism and overweight/obesity is more prevalent in ethnicities from Asia. Notoriously, overweight/obesity could be affected by age and sex. According to obesity epidemic in the United States, the overweight/obesity combined prevalence increase with age and more men than women were overweight/obesity, but there was no such trend regarding obesity ([@bb0160]). Thus, we performed a subgroup analysis in term of mean age and gender in present meta-analysis. There were significant associations between 825TT and overweight/obesity among those studies mean age under 30 years or males. In addition, the critical assessment of each original study quality is essential because the meta-analysis is a secondary analysis and evaluation of the original study. We adopted the NOS scale to assess the quality of each study. In subgroup analysis of study quality, we found the pooled effect of high quality studies was closer to the overall pooled effect in all inherited model.

Currently, there are several different definitions for overweight and obesity. BMI is the most widely used measures, which provide a useful population-level measure of overweight and obesity. However, BMI cutoff points for overweight and obesity differ in different regions. And in children and adolescents, BMI 85th and 95th percentiles was defined as overweight ([@bb0085], [@bb0050]). We separately analyzed the association of the *GNB3* c.825C \> T polymorphism with overweight or extremely obese alone and the results indicated the impact by the genetic factor of *GNB3* c.825C \> T polymorphism was greater in overweight than extremely obese. The potential reasons maybe that the extremely obese could be affected more significantly than other factors or other genetic factors.

Heterogeneity between included studies is a common problem in meta-analysis. In present meta-analysis, moderate heterogeneity was found in four inherited models. To investigate this problem in greater depth, subgroup analysis and meta-regression analysis showed that quality scores of included studies were the sources of heterogeneity in the four inherited model. And the *P* value of HWE and publication year were the sources of heterogeneity in the allelic model, homozygous model, and recessive model. Furthermore, the funnel plot and Egger\'s linear regression test and Begg\'s test indicate no apparent publication bias in the present meta-analysis. "Leave one out" sensitivity analyses indicated that the association was more significant after excluding some studies.

A previous meta-analysis by Souza et al. showed a trend (*P* = 0.053) associating CC and lower BMI under a fixed model ([@bb0130]). This suggests that the *GNB3* c.825C \> T polymorphism was thought to play a key role in overweight/obesity. Our analysis confirmed the association of the *GNB3* c.825C \> T polymorphism with overweight/obesity. More recently, a meta-analysis involving 10 studies by Tang et al. failed to observe association of *GNB3* c.825C \> T polymorphism and overweight/obesity in a fixed effect model under a homozygous model (TT versus CC) ([@bb0145]). Their results were inconsistent with the present meta-analysis. The difference could be explained by that they included a review published in 2000 by [@bb0120], of which data overlapped with the study published in 1999 by [@bb0115]. Moreover, they did not assess the association under other inherited models and perform the stratification analysis by the potential confounding variables. Several limitations in the current meta-analysis should be mentioned. Firstly, some included studies do not comply with HWE due to the fact that a very limited amount of studies reported the association between *GNB3* c.825C \> T and the overweight/obesity, which may influence the cause--effect relationship. Fortunately, the overall pooled effects were in line with the subgroup analysis consistent with the *P* value of HWE, which illustrates that our results were stable. Secondly, we had insufficient information regarding genotypes and allelic frequency by different sex. In addition, some authors were contacted via email with respect to missing information, but data was not available.

In conclusion, our results suggested that the presence of *GNB3* 825TT homozygote might be one of the genetic factors susceptible to overweight/obesity and that male or aged less than 30 years increases the genetic susceptibility. We also demonstrated that *GNB3* 825TT and overweight alone were significantly associated. Additional large sample size and well-studied association studies are needed to provide powerful evidence to the conclusions.
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###### 

Characteristics of studies of overweight/obesity and GNB3 c.825C \> T polymorphism.

Table 1

  Author              Year   Country        Ethnicity       Source of control   Genotyping method   BMI cut-off points   Group      Number    Allele and genotypes   Mean age (y)   Gender (M/F)   *P*~*HWE*~                              
  ------------------- ------ -------------- --------------- ------------------- ------------------- -------------------- ---------- --------- ---------------------- -------------- -------------- ------------ ----- ---------- --------- ----------
  Lee et al.          2015   Korea          Asian           PB                  TaqMan              85th                 Case       394       379                    409            85             209          100   8--9       231/163   0.023
  Control             1769   1746           1792            407                 932                 430                  8--9       875/894                                                                                                
  Hsiao et al.        2013   China          Asian           HB                  TaqMan              24                   Case       467       402                    532            87             228          152   About 40   333/134   0.188
  Control             505    441            569             89                  263                 153                  40 ± 12    257/247                                                                                                
  Wang et al.         2008   China          Asian           PB                  PCR--RFLP           25                   Case       129       137                    121            38             61           30    55 ± 10    85/44     0.495
  Control             270    285            255             78                  129                 63                   54 ± 11    140/130                                                                                                
  Chen et al.         2006   China          Asian           PB                  PCR--RFLP           23                   Case       161       149                    173            38             73           50    NA         58/103    0.001
  Control             313    358            268             88                  182                 43                   NA         151/162                                                                                                
  Zhou et al.         2005   China          Asian           PB                  PCR--RFLP           25                   Case       142       154                    130            43             68           31    \> 30      NA        0.584
  Control             85     83             87              19                  45                  21                   \> 30      NA                                                                                                     
  Lee et al.          2005   Korea          Asian           PB                  PCR--RFLP           25                   Case       130       132                    128            32             68           30    25 ± 3     130/0     0.082
  Control             152    166            138             40                  86                  26                   24 ± 3     152/0                                                                                                  
  Suwazono et al.     2004   Japan          Asian           PB                  PCR--RFLP           25                   Case       183       195                    171            52             91           40    42 ± 9     0/183     \< 0.001
  Control             989    1033           945             242                 549                 198                  38 ± 9     0/989                                                                                                  
  Suwazono et al.     2004   Japan          Asian           PB                  PCR--RFLP           25                   Case       322       322                    322            80             162          80    40 ± 9     322/0     0.179
  Control             1131   1144           1118            278                 588                 265                  38 ± 10    1131/0                                                                                                 
  Benjafield et al.   2001   Britain        Caucasian       PB                  PCR--RFLP           25                   Case       84        122                    46             42             38           4     48 ± 9     54/30     0.054
  Control             105    162            48              59                  44                  2                    48 ± 10    55/50                                                                                                  
  Hinney et al.       2001   Germany        Caucasian       PB                  PCR--RFLP           90th                 Case       491       695                    287            251            193          47    About 20   225/296   0.957
  Control             110    144            76              47                  50                  13                   25 ± 3     55/55                                                                                                  
  Ohshiro et al.      2001   Japan          Asian           PB                  PCR--RFLP           30                   Case       263       272                    254            71             130          62    About 50   146/117   0.872
  Control             150    148            152             37                  74                  39                   49 ± 1     80/70                                                                                                  
  Siffert et al.      1999   Germany        Caucasian       PB                  PCR--RFLP           25                   Case       92        108                    76             32             44           16    About 20   92/0      0.753
  Control             207    292            122             102                 88                  17                   About 20   207/0                                                                                                  
  Siffert et al.      1999   China          Asian           PB                  PCR--RFLP           25                   Case       186       166                    206            33             100          53    About 20   186/0     0.903
  Control             832    868            778             235                 416                 181                  About 20   832/0                                                                                                  
  Siffert et al.      1999   South Africa   Black African   PB                  PCR--RFLP           25                   Case       75        17                     133            0              17           58    About 20   75/0      0.706
  Control             201    68             334             5                   58                  138                  About 20   201/0                                                                                                  
  Siffert et al.      1999   Zimbabwe       Black African   PB                  PCR--RFLP           25                   Case       52        17                     87             1              15           36    About 20   52/0      0.753
  Control             406    151            661             15                  121                 270                  About 20   406/0                                                                                                  

Abbreviations: BMI, body mass index; PB, population based; HB, hospital based; HWE, Hardy--Weinberg equilibrium.

*P*~*HWE*~ indicates the *P* value of Hardy--Weinberg equilibrium.

###### 

Assessment study quality based on the Newcastle--Ottawa scale.

Table 2

  Author (year)                                Is the case definition adequate?   Representativeness of the cases   Selection of controls                Definition of controls   Comparability of cases and controls on the basis of the design or analysis   Ascertainment of exposure   Same method of ascertainment for cases and controls   Non-response rate   Total score
  -------------------------------------------- ---------------------------------- --------------------------------- ------------------------------------ ------------------------ ---------------------------------------------------------------------------- --------------------------- ----------------------------------------------------- ------------------- -------------
  [@bb0070]                                    ★                                  ★                                 ☆[c](#tf0015){ref-type="table-fn"}   ★                        ★☆                                                                           ★                           ★                                                     ☆                   6
  [@bb0060]                                    ★                                  ★                                 ★                                    ★                        ★☆                                                                           ★                           ★                                                     ☆                   7
  [@bb0155]                                    ★                                  ★                                 ★                                    ★                        ★☆                                                                           ★                           ★                                                     ☆                   7
  [@bb0015]                                    ★                                  ★                                 ☆                                    ★                        ☆☆                                                                           ★                           ★                                                     ☆                   5
  [@bb0165]                                    ★                                  ★                                 ★                                    ☆                        ☆☆                                                                           ★                           ★                                                     ☆                   5
  [@bb0065]                                    ★                                  ☆                                 ★                                    ★                        ★☆                                                                           ★                           ★                                                     ☆                   6
  [@bb0140][a](#tf0005){ref-type="table-fn"}   ★                                  ☆                                 ★                                    ☆                        ★☆                                                                           ★                           ★                                                     ☆                   5
  [@bb0140][b](#tf0010){ref-type="table-fn"}   ★                                  ☆                                 ☆[c](#tf0015){ref-type="table-fn"}   ☆                        ★☆                                                                           ★                           ★                                                     ☆                   4
  [@bb0010]                                    ★                                  ★                                 ★                                    ★                        ★★                                                                           ★                           ★                                                     ☆                   8
  [@bb0055]                                    ★                                  ★                                 ★                                    ★                        ★☆                                                                           ★                           ★                                                     ★                   8
  [@bb0095]                                    ★                                  ☆                                 ★                                    ☆                        ★★                                                                           ★                           ★                                                     ☆                   6
  [@bb0115]                                    ★                                  ★                                 ★                                    ★                        ★★                                                                           ★                           ★                                                     ☆                   8

Indicates inconsistency with Hardy--Weinberg equilibrium.

indicates that the subjects were female.

Indicates that the subjects were male.

###### 

Characteristics of studies of overweight or extremely obese and GNB3 c.825C \> T polymorphism.

Table 3

  Author              Year   Country        Ethnicity       Source of control   Genotyping method   BMI cut-off points   Group     Number    Allele and genotypes   Mean age (y)   Gender (M/F)   *P*~*HWE*~                           
  ------------------- ------ -------------- --------------- ------------------- ------------------- -------------------- --------- --------- ---------------------- -------------- -------------- ------------ ---- -------- --------- -------
  *Overweight*                                                                                                                                                                                                                         
  Hsiao et al.        2013   China          Asian           HB                  TaqMan              24--27               Case      291       249                    333            47             155          89   41 ± 1   204/87    0.188
  Control             505    505            441             569                 89                  263                  40 ± 12   257/247                                                                                             
  Siffert et al.      1999   Germany        Caucasian       HB                  PCR--RFLP           25--27               Case      70        85                     55             26             33           11   24 ± 3   70/0      0.753
  Control             207    292            122             102                 88                  17                   207/0                                                                                                         
  Siffert et al.      1999   China          Asian           HB                  PCR--RFLP           25--27               Case      128       118                    138            24             70           34   25 ± 4   128/0     0.903
  Control             832    868            778             235                 416                 181                  832/0                                                                                                         
  Siffert et al.      1999   South Africa   Black African   HB                  PCR--RFLP           25--27               Case      53        13                     93             0              13           40   22 ± 4   53/0      0.706
  Control             201    68             334             5                   58                  138                  201/0                                                                                                         
  Chen et al.         2006   China          Asian           PB                  PCR--RFLP           23--25               Case      57        58                     56             12             34           11   NA       58/103    0.001
  Control             313    358            268             88                  182                 43                                                                                                                                 
                                                                                                                                                                                                                                       
  *Extremely obese*                                                                                                                                                                                                                    
  Hinney et al.       2001   Germany        Caucasian       PB                  PCR--RFLP           99th                 Case      440       622                    258            226            170          44   14 ± 3   199/241   0.957
  Control             110    144            76              47                  50                  13                   25 ± 3    55/55                                                                                               
  Ohshiro et al.      2001   Japan          Asian           PB                  PCR--RFLP           35                   Case      55        57                     53             13             31           11   50 ± 1   28/27     0.872
  Control             150    148            152             37                  74                  39                   49 ± 1    80/70                                                                                               

Abbreviations: BMI, body mass index; PB, population based; HB, hospital based; HWE, Hardy--Weinberg equilibrium.

*P*~*HWE*~ indicates the *P* value of Hardy--Weinberg equilibrium.

###### 

Pooled ORs and 95% CIs of the association between GNB3 c.825C \> T polymorphism and overweight/obesity in both fixed and random effect model.

Table 4

  Inherited model    Fixed effect model   Random effect model   *I*^2^ (%)   *P*^*H*^   Egger *P*    Begg P                          
  ------------------ -------------------- --------------------- ------------ ---------- ------------ -------- ------ ------- ------- -------
  T vs. C            1.08                 1.02--1.16            0.017        1.10       0.99--1.22   0.076    53.3   0.008   0.412   0.520
  TT vs. CC          1.19                 1.04--1.36            0.014        1.23       0.98--1.54   0.078    54.0   0.007   0.296   0.656
  CT vs. CC          1.00                 0.89--1.12            0.994        1.00       0.87--1.14   0.945    16.9   0.264   0.454   0.299
  TT vs. (CT + CC)   1.19                 1.06--1.32            0.002        1.22       1.04--1.44   0.015    46.3   0.025   0.294   0.458
  (TT + CT) vs. CC   1.05                 0.94--1.17            0.350        1.06       0.91--1.22   0.484    38.6   0.063   0.381   0.458

*P*^*H*^ indicates the *P* value of heterogeneity.

###### 

Pooled ORs and 95% CIs of subgroup analysis.

Table 5

                           T vs. C             TT vs. CC   TT vs. (CT + CC)   (TT + CT) vs. CC                                                                                    
  ------------------------ ------------------- ----------- ------------------ -------------------- ------- ------ ------------------- ------- ------ -------------------- ------- ------
  HWE                                                                                                                                                                             
   Yes (n = 12)            1.09 (0.96--1.23)   0.184       49.7               1.18 (0.91--1.54)    0.213   47.3   1.15 (1.00--1.32)   0.043   4.5    1.07 (0.89--1.30)    0.504   45.3
   No (n = 3)              1.14 (0.89--1.46)   0.289       75.0               1.37 (0.79--2.35)    0.259   78.5   1.46 (0.84--2.52)   0.178   85.6   1.03 (0.82--1.29)    0.815   25.3
  Ethnicity                                                                                                                                                                       
   Asian (n = 10)          1.08 (0.97--1.19)   0.174       48.9               1.18 (0.94--1.48)    0.165   56.1   1.19 (1.00--1.43)   0.055   54.2   1.03 (0.89--1.20)    0.689   31.9
   Caucasian (n = 3)       1.18 (0.72--1.92)   0.517       80.6               1.64 (0.52--5.15)    0.399   76.4   1.50 (0.64--3.55)   0.355   0      1.16 (0.65--2.09)    0.605   75.6
   Black African (n = 2)   1.36 (0.92--2.01)   0.129       0                  2.65 (0.49--14.18)   0.256   0      1.33 (0.86--2.06)   0.202   62.6   2.52 (0.47--13.45)   0.278   0
  Mean age                                                                                                                                                                        
   Less than 30 (n = 7)    1.19 (0.99--1.44)   0.067       60.9               1.48 (0.99--2.21)    0.057   54.7   1.26 (1.04--1.55)   0.029   22.9   1.25 (0.91--1.70)    0.171   58.0
   More than 30 (n = 7)    0.99 (0.90--1.09)   0.852       0                  0.97 (0.80--1.17)    0.759   0      1.06 (0.91--1.23)   0.478   0      0.92 (0.80--1.08)    0.311   0
   NA (n = 1)              1.55 (1.18--2.03)   0.001       --                 2.69 (1.54--4.70)    0.000   --     2.83 (1.78--4.50)   0.000   --     1.27 (0.82--1.96)    0.293   --
  Gender                                                                                                                                                                          
   All (n = 8)             1.03 (0.89--1.18)   0.702       53.6               1.08 (0.80--1.46)    0.631   56.2   1.15 (0.87--1.51)   0.332   64.1   0.98 (0.85--1.12)    0.742   0
   Male (n = 6)            1.27 (1.06--1.51)   0.008       44.8               1.68 (1.11--2.54)    0.014   46.9   1.31 (1.08--1.57)   0.005   0.9    1.38 (1.00--1.88)    0.049   45.3
   Female (n = 1)          0.96 (0.77--1.20)   0.711       --                 0.94 (0.60--1.48)    0.790   --     1.12 (0.76--1.64)   0.570   --     0.82 (0.57--1.16)    0.259   --
  Study quality                                                                                                                                                                   
   High (n = 8)            1.20 (0.97--1.50)   0.093       59.7               1.56 (0.94--2.60)    0.087   54.4   1.30 (1.01--1.66)   0.040   17.5   1.27 (0.89--1.82)    0.188   58.4
   Low (n = 7)             1.05 (0.94--1.17)   0.388       41.8               1.11 (0.88--1.41)    0.372   49.7   1.19 (0.96--1.47)   0.118   61.0   0.98 (0.86--1.11)    0.730   0

n is the number of studies.

###### 

Pooled ORs and 95% CIs of the association between GNB3 c.825C \> T polymorphism and overweight or extremely obese.

Table 6

  Inherited model    Overweight   Extremely obese                                             
  ------------------ ------------ ----------------- ------- ----- ------ ------------ ------- ------
  T vs. C            1.21         1.05--1.38        0.008   8.5   0.82   0.64--1.06   0.140   0
  TT vs. CC          1.51         1.12--2.04        0.007   7.1   0.74   0.42--1.29   0.288   0
  CT vs. CC          1.36         1.05--1.75        0.018   0     0.81   0.55--1.19   0.280   26.3
  TT vs. (CT + CC)   1.21         0.98--1.51        0.084   0     0.77   0.47--1.27   0.307   0
  (TT + CT) vs. CC   1.42         1.11--1.81        0.005   0     0.78   0.54--1.12   0.184   0
